Outcomes, Safety of Weight-Based Bedaquiline in Children With Multidrug-Resistant Tuberculosis
Researchers assessed the pharmacokinetic profile and safety of weight-based bedaquiline among children with multidrug-resistant tuberculosis.
Researchers assessed the pharmacokinetic profile and safety of weight-based bedaquiline among children with multidrug-resistant tuberculosis.
To what extent does second-hand smoke exposure affect respiratory health — and does the effect of this exposure persist over time?
From August 2020 through September 2021, about 7 percent of lung transplantations were performed in patients with COVID-19-related respiratory failure.
Meeting the ATS-recommended air quality standards (limit long-term fine particular matter to 8 µg/m3) would yield significant health benefits.
Researchers analyzed hospitalized patient data from US medical facilities to assess hospital utilization on the basis of SARS-CoV-2 status.
Investigators compared the clinical course, risk factors, and outcomes of cancer patients with COVID-19 with non-cancer patients with COVID-19.
Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.
Oral voriconazole may be more effective than oral itraconazole for initial maintenance therapy in patients with chronic pulmonary aspergillosis.
Prospective surveillance of enterovirus D68 is contributing to a better understanding of its epidemiology and should be continued.
Nabriva Therapeutics announced the submission of 2 NDAs to the FDA for the oral and IV formulations of lefamulin for the treatment of community-acquired bacterial pneumonia.